Collin Todd

Collin Todd brings strategy and business development experience to the Odyssey team with a career spanning multiple early-stage biotech companies, venture capital, and investment banking. Prior to Odyssey, Mr. Todd was Sr. Director of Strategy and Business Development at SpringWorks Therapeutics, where he helped build the company and corporate strategy following founding with two programs into a public company with 17 active programs and trials across oncology and rare disease. He also served as Sr. Manager of Strategy at Moderna Therapeutics focused on the cardiovascular and rare disease portfolio. Prior to biotech, he worked as a private equity analyst at OrbiMed Advisors and in healthcare investment banking at Bank of America Merrill Lynch. Mr. Todd earned his BA in Economics at the University of California, Los Angeles.